| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA665162 | Functional | Concentration required to inhibit the growth of chang liver cells. | Homo sapiens | 17 | ALA1129930 | assay format | Scientific Literature | |
| 2. | ALA669468 | Binding | In vitro inhibitory concentration against beef liver dihydrofolate reductase | Bos taurus | 4 | ALA1122902 | assay format | Scientific Literature | |
| 3. | ALA677066 | Binding | Activity (apparent Km ) was evaluated in vitro by purified mouse liver folate polyglutamate synthetase (FPGS). | 1 | ALA1122902 | assay format | Scientific Literature | ||
| 4. | ALA678778 | Binding | Activity (relative Km) was evaluated in vitro by purified mouse liver folate polyglutamate synthetase (FPGS). | 1 | ALA1122902 | assay format | Scientific Literature | ||
| 5. | ALA678780 | Binding | Activity (relative Vmax) was evaluated in vitro by purified mouse liver folate polyglutamate synthetase (FPGS). | 1 | ALA1122902 | assay format | Scientific Literature | ||
| 6. | ALA708821 | Functional | Concentration required to inhibit the growth of L1210 cells. | Mus musculus | 17 | ALA1129930 | cell-based format | Scientific Literature | |
| 7. | ALA712031 | Functional | Inhibitory concentration against the growth of L1210 murine leukemia cells in tissue culture. | Mus musculus | 2 | ALA1122902 | cell-based format | Scientific Literature | |
| 8. | ALA814749 | Binding | In vitro inhibitory concentration against Lactobacillus casei thymidylate synthetase | Lacticaseibacillus casei | 4 | ALA1122902 | single protein format | Scientific Literature | |
| 9. | ALA734929 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 23 at intraperitoneal dose of 12 mg/kg | Mus musculus | 6 | ALA1129930 | organism-based format | Scientific Literature | |
| 10. | ALA734930 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 23 at intraperitoneal dose of 18 mg/kg | Mus musculus | 1 | ALA1129930 | organism-based format | Scientific Literature | |
| 11. | ALA734934 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 23 at intraperitoneal dose of 6 mg/kg | Mus musculus | 16 | ALA1129930 | organism-based format | Scientific Literature | |
| 12. | ALA735883 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 30 at intraperitoneal dose of 12 mg/kg | Mus musculus | 6 | ALA1129930 | organism-based format | Scientific Literature | |
| 13. | ALA735884 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 30 at intraperitoneal dose of 18 mg/kg | Mus musculus | 1 | ALA1129930 | organism-based format | Scientific Literature | |
| 14. | ALA736121 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 30 at intraperitoneal dose of 6 mg/kg | Mus musculus | 16 | ALA1129930 | organism-based format | Scientific Literature | |
| 15. | ALA733399 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 37 at intraperitoneal dose of 12 mg/kg | Mus musculus | 6 | ALA1129930 | organism-based format | Scientific Literature | |
| 16. | ALA733400 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 37 at intraperitoneal dose of 18 mg/kg | Mus musculus | 1 | ALA1129930 | organism-based format | Scientific Literature | |
| 17. | ALA736286 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 37 at intraperitoneal dose of 6 mg/kg | Mus musculus | 16 | ALA1129930 | organism-based format | Scientific Literature | |
| 18. | ALA735205 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 44 at intraperitoneal dose of 12 mg/kg | Mus musculus | 6 | ALA1129930 | organism-based format | Scientific Literature | |
| 19. | ALA735206 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 44 at intraperitoneal dose of 18 mg/kg | Mus musculus | 1 | ALA1129930 | organism-based format | Scientific Literature | |
| 20. | ALA735210 | Functional | Incidence of disease (mouse type II collagen) was scored as the percentage of animals within each experimental group that exhibited joint or limb inflammation on day 44 at intraperitoneal dose of 6 mg/kg | Mus musculus | 16 | ALA1129930 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!